Tandem Diabetes Care, Inc. (FRA:TD5A)

Market Cap	1.14B -50.5%
Revenue (ttm)	858.27M +17.9%
Net Income	-173.33M
EPS	-2.60
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Average Volume	18
Open	16.40
Previous Close	15.82
Day's Range	16.40 - 16.43
52-Week Range	8.79 - 35.65
Beta	n/a
RSI	41.62
Earnings Date	Feb 19, 2026

About Tandem Diabetes Care

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software fr...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,650
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TD5A

Financial Performance

In 2024, Tandem Diabetes Care's revenue was $940.20 million, an increase of 25.74% compared to the previous year's $747.72 million. Losses were -$96.03 million, -56.86% less than in 2023.

Financial numbers in USD